Source: International Business Times
Moderna shares hover around 52-week lows. US biotech firm Moderna (Nasdaq: MRNA) shares rose by over 4% on Tuesday to close at $24. 84 (£18.
Aller á la Source
Nouvelles connexes
List des news
Moderna Shares Surge After Recording Positive Phase 4 Prelim Data on COVID-19 Drug
Moderna
International Business Times
ha 14h
